212 related articles for article (PubMed ID: 31387105)
41. Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.
Xia Y; Mao J; Chen Y; Wang D; Cao L; Yao S; Fu H; Du L; Liu A
Pediatr Nephrol; 2011 Jul; 26(7):1083-8. PubMed ID: 21387156
[TBL] [Abstract][Full Text] [Related]
42. Serum levels of alpha-smooth muscle actin and c-Met as biomarkers of the degree of severity of Henoch-Schonlein purpura nephritis.
Zhang L; Han C; Sun C; Meng H; Ye F; Na S; Chen F; Zhang D; Jin X
Transl Res; 2013 Jan; 161(1):26-36. PubMed ID: 23041443
[TBL] [Abstract][Full Text] [Related]
43. The relationship between red cell distribution width and the risk of Henoch-Schönlein purpura nephritis.
Zhu X; Zhang M; Lan F; Wei H; He Q; Li S; Qin X
Br J Biomed Sci; 2018 Jan; 75(1):30-35. PubMed ID: 28990845
[TBL] [Abstract][Full Text] [Related]
44. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
Coppo R; Andrulli S; Amore A; Gianoglio B; Conti G; Peruzzi L; Locatelli F; Cagnoli L
Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
[TBL] [Abstract][Full Text] [Related]
45. Differences in pathological characteristics and laboratory indicators in adult and pediatric patients with Henoch-Schönlein purpura nephritis.
Liu Z; Wei YD; Hou Y; Xu Y; Li XJ; Du YJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):659-666. PubMed ID: 27752908
[TBL] [Abstract][Full Text] [Related]
46. MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Schönlein purpura nephritis.
Yun D; Kim DK; Oh KH; Joo KW; Moon KC; Kim YS; Lee K; Han SS
BMC Nephrol; 2020 Jan; 21(1):33. PubMed ID: 32000703
[TBL] [Abstract][Full Text] [Related]
47. Correlation Between Clinicaland Pathological Characteristics of Henoch-Schönlein Purpura Nephritis in Adults.
Lu S; Liu D; Xiao J; Cheng G; Zhang X; Liu Z; Zhao Z
Iran J Kidney Dis; 2016 Jan; 11(1):12-17. PubMed ID: 28174347
[TBL] [Abstract][Full Text] [Related]
48. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
Yu M; Song X; Guo J; Feng Q; Tian J
Eur J Pediatr; 2024 Jul; 183(7):3117-3128. PubMed ID: 38668796
[TBL] [Abstract][Full Text] [Related]
49. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
50. The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Schönlein purpura nephritis: A meta-analysis.
Tan J; Tang Y; Zhong Z; Yan S; Tan L; Tarun P; Qin W
Int Urol Nephrol; 2019 Jun; 51(6):975-985. PubMed ID: 30989564
[TBL] [Abstract][Full Text] [Related]
51. Obesity is associated with Henoch-Schönlein Purpura Nephritis and development of end-stage renal disease in children.
Zheng X; Chen Q; Chen L
Ren Fail; 2019 Nov; 41(1):1016-1020. PubMed ID: 31735105
[No Abstract] [Full Text] [Related]
52. [Function of CD4(+) CD25(+) regulatory T cells in Henoch-Schonlein purpura nephritis in children].
Shao X; Jiang C; Li Y; Jiang X; Xu H; Ying P; Qiu J; Lin J; Zheng S; Chang L; Huang Y
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):516-20. PubMed ID: 25224057
[TBL] [Abstract][Full Text] [Related]
53. Association of kidney biopsy findings with short- and medium-term outcomes in children with moderate-to-severe IgA vasculitis nephritis.
Clavé S; Sordet M; Tsimaratos M; Decramer S; Fila M; Guigonis V; Faudeux C; Daniel L; Torrents J; Boucekine M; Harambat J; Rousset-Rouvière C
Eur J Pediatr; 2021 Oct; 180(10):3209-3218. PubMed ID: 33934234
[TBL] [Abstract][Full Text] [Related]
54. [A clinico-pathological comparison between Henoch-Schonlein purpura nephritis and IgA nephropathy in children].
Guo HX; Zhang JJ; Shi PP; Fu SQ; Zhang LG; Wang M; Lu FX
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):506-9. PubMed ID: 22809602
[TBL] [Abstract][Full Text] [Related]
55. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?
Davin JC; Ten Berge IJ; Weening JJ
Kidney Int; 2001 Mar; 59(3):823-34. PubMed ID: 11231337
[TBL] [Abstract][Full Text] [Related]
56. Kidney Injury Molecule-1 Level is Associated with the Severity of Renal Interstitial Injury and Prognosis in Adult Henoch-Schönlein Purpura Nephritis.
Zhang Y; Li A; Wen J; Zhen J; Hao Q; Zhang Y; Hu Z; Xiao X
Arch Med Res; 2017 Jul; 48(5):449-458. PubMed ID: 29122357
[TBL] [Abstract][Full Text] [Related]
57. [Clinical characteristics, pathology, and prognosis of children with diffuse endocapillary proliferative Henoch-Schönlein purpura nephritis].
Yin TT; Peng XJ; Fu R; Wang Y; Lyu Y; Deng YQ; Fu JQ; Zhang ZH
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):837-842. PubMed ID: 37668032
[TBL] [Abstract][Full Text] [Related]
58. [Clinical analysis of proteinuria and glomerular lesions in Henoch-Schönlein purpura nephritis of adults].
Liu DY; Wen YB; Li H; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):237-40. PubMed ID: 15960273
[TBL] [Abstract][Full Text] [Related]
59. Leflunomide in addition to steroids improves proteinuria and renal function in adult Henoch-Schoenlein nephritis with nephrotic proteinuria.
Zhang Y; Gao Y; Zhang Z; Liu G; He H; Liu L
Nephrology (Carlton); 2014 Feb; 19(2):94-100. PubMed ID: 24171710
[TBL] [Abstract][Full Text] [Related]
60. Association of endothelial nitric oxide synthase gene polymorphism with the risk of Henoch-Schönlein purpura/Henoch-Schönlein purpura nephritis.
Zhong W; Zhou TB; Jiang Z
Ren Fail; 2015 Apr; 37(3):372-6. PubMed ID: 25585947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
